Private equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice are acquiring R1 RCM in a deal valued at $8.9 billion that is expected to close by the end of the year.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
